Participated · Series A · May 2026

Founded in 2021 by Hai Long Bui and Hai Nam Bui, SoBanHang (operating under Finan PTE. LTD.) offers a mobile-first business management platform for MSMEs to manage sales, inventory, customer transactions, revenue tracking, and invoicing in one application. The company embeds banking and lending services into merchant workflows via partnerships with financial institutions such as Shinhan Bank Vietnam. Its product emphasizes integrated merchant banking and embedded finance capabilities. Financially, the company recently raised $3.8M in a Pre-Series A led by Hong Leong Bank to support product development and regional expansion across Southeast Asia. SoBanHang plans to use the new capital to strengthen embedded finance features and scale its regional footprint. The articles did not report user, revenue, or valuation metrics.

Participated · Series A · Aug 2025

SixSense offers an AI-powered platform that converts raw production data—defect images and equipment signals—into real-time insights for semiconductor fabs. The platform delivers defect detection, root-cause analysis, and failure prediction and is designed for process engineers to deploy models in under two days without coding. SixSense targets large chipmakers including foundries, OSATs, and IDMs and is already used by customers such as GlobalFoundries and JCET. Its system has processed more than 100 million chips and customers report up to 30% faster production cycles, a 1–2% boost in yield, and a 90% reduction in manual inspection work. The solution is compatible with inspection equipment covering over 60% of the global market. Founded by Akanksha Jagwani and Avni Agarwal, the company is expanding from fabs in Singapore, Malaysia, Taiwan, and Israel into the U.S. SixSense provides a no-code computer-vision platform that builds, monitors, and maintains AI models to detect manufacturing defects at scale. Its software scans millions of products at high speed and is used by large multinational semiconductor customers to make manual inspection more efficient and consistent. The platform includes built-in explainability so factory engineers can understand why defects occur and increasingly predict equipment anomalies before they become product defects. SixSense serves semiconductor manufacturers and emphasizes high-throughput defect classification across factories. The company plans to use new funding to scale its team across research and development, customer success, and sales to support growth. SixSense was founded in 2018 and operates out of Singapore and India.

Participated · Series A · Jun 2025

Elfie is a free digital health super-app that combines self-monitoring tools, AI-driven coaching, gamification, and real-world rewards to help users manage chronic conditions. Launched in 2021, the app has grown to over 700,000 users across four continents and is available in 35 countries, with plans to expand to 10 more by the end of 2025. Elfie says its clinically validated interventions and behavioral-science approaches have driven 30%+ improvements in adherence for key pharmaceutical partners and measurable health improvements for users. The platform is medically approved across multiple regions and remains 100% free for users, with all revenue generated through enterprise partnerships. Elfie has secured multimillion-dollar partnerships with global pharma leaders and is piloting programs with global insurance carriers to reduce claim costs and loss ratios. The company plans to use new funding to accelerate user acquisition via pharma and insurance partnerships, expand its U.S. team (product, engineering, go-to-market), and launch Elfie Research, a decentralized clinical trial platform to generate real-world evidence. Elfie is a Singapore-based health monitoring platform that rewards patients for getting healthier. Its core product monitors health metrics and uses a rewards model to incentivize healthier behavior. Recent regulatory filings indicate the company has raised at least $4 million in fresh funding. The article cites those regulatory filings as the source of the funding information. No operating metrics, revenue figures, or future plans were disclosed in the article.

Participated · Equity · Feb 2025

HD operates HDmall, a marketplace that aggregates healthcare productized services—from health check-ups and vaccinations to surgeries—helping users find providers, compare options, and access installment payments. The platform lists over 30,000 SKUs from more than 2,500 hospitals and clinics, works with pharmaceutical partners, and serves roughly 400,000 paying customers across Thailand and Indonesia. HD reports about $100 million in annual gross transaction volume and aims to reach 5,000 healthcare providers and 600,000 patients by 2025. The company has built Jib AI, an AI chatbot trained on anonymized product, transaction, and chat-commerce data; roughly 60% of customer interactions are now handled by AI agents. Over the next 12 months HD plans to add order and refund processing, assisted checkouts, scheduling, EHR checking, medical information retrieval, and AI-powered asynchronous virtual care; over two years it plans to expand partnerships with insurers, pharma, employers, and educational institutions. HD also plans geographic expansion into Vietnam and Myanmar in addition to its existing Thailand and Indonesia operations. HD began as a marketplace for third-party healthcare and surgery services (HDmall) and is now building conversational AI tailored to the Southeast Asian healthcare customer journey. The company plans to train chatbots on its proprietary, anonymized transaction, chat, FAQ, and product catalog data gathered over years of operations. HD has worked with roughly 2,000 healthcare providers and reports that 30–40% of its transactions occur through chat commerce. Management aims to roll out a marketplace chatbot within three months and open the technology to third parties by the end of the year, creating a new SaaS revenue stream alongside marketplace commissions. The startup positions its product as vertical, domain-specific AI—“the Sierra AI of the Southeast Asian healthcare industry”—using local data as a competitive moat. During the COVID-19 period HD cut costs, and after the pandemic it moved toward profitability with roughly 2x year-on-year growth; the team accepted a moderate valuation to accelerate growth. HD operates a marketplace for outpatient services and a recently launched private-label surgery service (HDcare) that connects surgeons in private practice, cost-conscious patients, and vacant hospital operating rooms. The platform reports a supply of over 20 operating rooms across Thailand and Indonesia, potential access to more via 1,500 healthcare providers on its marketplace, and over 40 types of surgeries lined up. HD aims to scale HDcare to 200 surgeries performed per quarter by Q4 2023. The company monetizes via transaction cuts, listing fees from providers, and healthcare marketing solutions. Since its founding four years ago and based in Bangkok, HD has served around 250,000 patients and saw 7x sales growth during the pandemic, targeting 2–3x growth in the post-COVID years. HD positions itself as enabling offline medical providers with digital tools rather than competing with them.

Participated · Seed · Dec 2024

Little John develops a generative AI SaaS platform aimed at empowering independent insurance brokers with operational tools for risk placement, compliance, and productivity. The startup targets the €1.5 trillion European insurance market and plans to launch its first GenAI-powered tool in Spring 2025. A beta will be available to selected brokers in the "Sherwood community" in February 2025 to gather feedback and refine usability. The founding team combines insurance and tech expertise, including CEO Olivier Legrand and former Leocare COO Grégoire Rastoul, along with experienced CTO Pierre Sigwalt and advisor Renaud de Pressigny. Little John raised early funding to develop its GenAI tools and foster a collaborative ecosystem enabling brokers to pool resources and expertise against larger competitors.